AIRMESS 2021 & ICAST 2021

Organized by:

Click here to join AIRMESS website

Event Introduction

◊ Swiss Stem Cell Foundation

Adipose tissue is a powerful source of stem cells for regenerative medicine and the use of these cells in treating human disease are becoming standard in these times, where several clinical trials are running worldwide to check the feasibility but also the efficacy of mesenchymal stem cells for medical treatments. A central figure in the collection of ASCs is the plastic surgeon that can be considered the first step in the process of disposing ultimately of stem cell therapies. Harvested cells are processed and/or cryopreserved for years and eventually used in authorized stem cell treatments. An emerging domain of treatment rely on safe and standardized GMP- prepared cells or expanded cells for autologous or even allogeneic use. This year’s meeting address expansion processes and eventual cryopreservation of adipose-derived mesenchymal stem cells for patient’s treatment with a focus on intra-venous injection of cells. The final aim of the meeting is thus to develop awareness that regenerative medicine is an interdisciplinary process where many actors are involved from the plastic surgeon to the final specialist user and we are just at the beginning to show how it could be conceived and designed to work in the real world.

◊ AIRMESS

The standardization of autologous therapies to promote innovative biotechnologies in medicine and plastic surgery, in particular in regenerative fields, for hair loss appears to be essential. Advances in autologous stem cell-based therapy (ASC- BT) and in autologous not-activated platelet-rich plasma (A-N-A-PRP) or autologous activated PRP (A-A-PRP) use, aiming to improve hair regrowth (HR) by in vitro and in vivo regeneration, should be performed. The effects of growth factors (GFs), released during ASC- BT and contained in A-N-A-PRP and A-A- PRP, represent these advances, through cell proliferation/differentiation, and neo- angiogenesis improvement. As is known, A-N-A-PRP and A-A-PRP contain many signaling proteins and after platelet activation discharge several major GFs such as PDGF, b-FGF, EGF, VEGF, TGF-β, and IGF-1 Every one of these is implicated in a specific biomolecular pathway during HR. Manufacturing platelet recommendations and steering on their employment in regenerative fields have been performed. On the same line, the Academy of International Regenerative Medicine & Surgery Societies (AIRMESS) decided to present, the ASC-BT and PRP’s guidelines.

In fact, a significant article number on the different procedures for A-N-A-PRP, A-A-PRP preparation, and on ASC-BT use have been published, but the results are often contrasting, also due to a wide biological and temporal variation of GFs and platelets and also for the different procedures of stem cell isolation such as enzymatic versus mechanic The aim of this congress is to discuss the impact of different PRP and ASC-BT preparation methods on HR, describing the related European rules and bio- molecular pathway. We believe that the future will be based on regenerative -based therapies. The aim of this congress is to discuss the impact of different PRP and ASC-BT preparation methods on HR, the data analyzed intended to clarify any doubts regarding the molecular mechanism in which PRP and ASC-BT are involved, suggesting recommendations in HR. 

With the participation of:

◊ Diamond Sponsors

Gold Sponsor

Silver Sponsor

Sponsors

is recognized by :

◊ Swiss Orthopaedics with 5 hours credit of post-graduated formation.

◊ Swiss Plastic Surgery Association with the following credits: 4 Credits (fachspezifisch SWISS PLASTIC SURGERY) und 4 Credits free FB.

DOWNLOAD AGENDA AIRMESS ICAST 2021 HERE

9.00-9.30 Registration and Coffee - Exhibit Hall

◊ First PART - ICAST 2021 (by Dr. Soldati - Swiss Stem Cell Foundation)

9.50-9.40 Welcome

9.40-10.10 Defining new criteria for adipose-derived stem cell use: a multicentric experience in Marseille and Lugano - Jeremy Magalon, Aix-Marseille University, France

Video Nordmark 2 min 

10.10-10.40 A new advanced cell therapy medicinal product in Switzerland for aesthetic purposes. - Luca Mariotta, Swiss Stem Cells Biotech, Vacallo, Switzerland

10.40-11.10 Coffee Break - Exhibit Hall

11.10-11.40 Stem cell expansion for therapeutic use. - Gianni Soldati, Swiss Stem Cell Foundation, Lugano, Switzerland

Video Cytori 2 min 

11.40-12.20 ADRCs – The Secret Mechanism of Action - Matthew Feshbach Tampa FL, USA

12.20-12.30 Discussion

12.30-14.00 Lunch - Exhibit Hall

◊ Second PART - AIRMESS Event 2021 (by Dr. Menkles - Academy of International Regenerative Medicine & Surgery Society ) 14.00-14.20 My strategy in fine tuning regenerative medicine for patients suffering from hair loss. - John Cole, Atlanta, USA

14.20-14.40 Human follicle stem cells and platelet rich plasma in androgenic alopecia: clinical trichoscopic and histological evaluation. - Pietro Gentile, Roma, Italy

14.40-15.00 Stromal vascular tissue, Human follicle stem cells, platelet rich plasma: What strategy? Results of a multicentric study. - Sophie Menkes, Geneva, Switzerland

Video Bimini 2 min 

15.00-15.20 My strategy in advanced hair therapies. - Katarina Andjelkov, Belgrade, Serbia

Video Human Med 2 min

Video Tricopat 2 min

Video Beautifill 2 min 

15.30-16.15 Cellular and Non-Cellular Paracrine Factors in Hair Follicle Cycling and Male/Female Hair Loss Etiology and Management. - Gordon Sasaki, Pasadena, USA

16.15-17.30 Discussion and Final remarks.